These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35336868)

  • 1. Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens.
    Yadav PD; Gupta N; Potdar V; Mohandas S; Sahay RR; Sarkale P; Shete AM; Razdan A; Patil DY; Nyayanit DA; Joshi Y; Patil S; Majumdar T; Dighe H; Malhotra B; Shastri J; Abraham P
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model.
    Yadav P; Mohandas S; Sarkale P; Nyayanit D; Shete A; Sahay R; Potdar V; Baradkar S; Gupta N; Sapkal G; Abraham P; Panda S; Bhargava B
    J Infect Public Health; 2022 Feb; 15(2):164-171. PubMed ID: 34959053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers.
    Yadav PD; Sarkale P; Razdan A; Gupta N; Nyayanit DA; Sahay RR; Potdar V; Patil DY; Baradkar S; Kumar A; Aggarwal N; Shete AM; Kaur H; Mohandas S
    J Infect Public Health; 2022 Feb; 15(2):182-186. PubMed ID: 34974274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of SARS-CoV-2 in cell lines used in public health surveillance programmes with special emphasis on biosafety.
    Pawar SD; Kode SS; Keng SS; Tare DS; Diop OM; Abraham P; Sharma DK; Sangal L; Yadav PD; Potdar VA
    Indian J Med Res; 2022 Jan; 155(1):129-135. PubMed ID: 35859439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ultrastructural and genomic study on the SARS-CoV-2 variant B.1.210 circulating during the first wave of COVID-19 pandemic in India.
    Kumar N; Santhoshkumar R; Prasad P; George AK; Aiyar J; Joshi S; Narayanappa G; Desai AS; Ravi V; Venkataswamy MM
    Indian J Med Microbiol; 2023; 41():45-52. PubMed ID: 36870749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
    Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
    Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
    [No Abstract]   [Full Text] [Related]  

  • 9. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
    Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
    Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.
    McMahan K; Giffin V; Tostanoski LH; Chung B; Siamatu M; Suthar MS; Halfmann P; Kawaoka Y; Piedra-Mora C; Jain N; Ducat S; Kar S; Andersen H; Lewis MG; Martinot AJ; Barouch DH
    Med; 2022 Apr; 3(4):262-268.e4. PubMed ID: 35313451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.
    Yamada S; Fukushi S; Kinoshita H; Ohnishi M; Suzuki T; Fujimoto T; Saijo M; Maeda K;
    BMJ Open Respir Res; 2021 Feb; 8(1):. PubMed ID: 33627333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.
    Rissmann M; Noack D; van Riel D; Schmitz KS; de Vries RD; van Run P; Lamers MM; Geurts van Kessel CH; Koopmans MPG; Fouchier RAM; Kuiken T; Haagmans BL; Rockx B
    Emerg Microbes Infect; 2022 Dec; 11(1):1778-1786. PubMed ID: 35787236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First isolation and characterization of SARS-CoV-2 from COVID-19 patient of North East India.
    Jakharia A; Borkakoty B; Pait S; Baruah G; Hazarika R; Biswas D
    Indian J Pathol Microbiol; 2024; 67(1):133-139. PubMed ID: 38358202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.
    Cheng YW; Chao TL; Li CL; Wang SH; Kao HC; Tsai YM; Wang HY; Hsieh CL; Lin YY; Chen PJ; Chang SY; Yeh SH
    mBio; 2021 Aug; 12(4):e0058721. PubMed ID: 34311586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells.
    Aiewsakun P; Phumiphanjarphak W; Ludowyke N; Purwono PB; Manopwisedjaroen S; Srisaowakarn C; Ekronarongchai S; Suksatu A; Yuvaniyama J; Thitithanyanont A
    Genome Biol Evol; 2023 Apr; 15(4):. PubMed ID: 36852863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters.
    Su W; Choy KT; Gu H; Sia SF; Cheng KM; Nizami SIN; Krishnan P; Ng YM; Chang LDJ; Liu Y; Cheng SMS; Peiris M; Poon LLM; Nicholls JM; Yen HL
    J Infect Dis; 2023 May; 227(10):1143-1152. PubMed ID: 35776136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.
    Hui KPY; Ho JCW; Cheung MC; Ng KC; Ching RHH; Lai KL; Kam TT; Gu H; Sit KY; Hsin MKY; Au TWK; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Nature; 2022 Mar; 603(7902):715-720. PubMed ID: 35104836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of SARS-CoV-2 from COVID-19 Patients and an Asymptomatic Individual.
    Hishiki T; Usui K; An T; Suzuki R; Sakuragi JI; Tanaka Y; Matsuki Y; Kawai J; Kogo Y; Hayashizaki Y; Takasaki T
    Jpn J Infect Dis; 2022 May; 75(3):277-280. PubMed ID: 34719530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.